Leigh MacMillan

microscope
June 23, 2016

VU takes key role in cancer drug discovery consortium

Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery.

By Leigh MacMillan
June 6, 2016

Pulmonary fibrosis culprits

New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease.

By Leigh MacMillan
June 2, 2016

Alzheimer’s risk gene in younger adults

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age.

By Leigh MacMillan
May 19, 2016

Promise of discovery drives Biomedical Sciences graduates

In a twist on the usual research narrative, Justin Siemann, Ph.D., who celebrated his doctoral degree in Neuroscience at last week’s Graduate School Commencement, conducted research on patients first, and then moved to the laboratory bench.

By Leigh MacMillan
May 5, 2016

Current cancer drug discovery method flawed: VUMC study

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

By Leigh MacMillan
May 3, 2016

Drug combos for glioblastoma

Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment.

By Leigh MacMillan
April 28, 2016

Cancer expert Thompson to deliver May 5 Flexner Discovery Lecture

Craig Thompson, M.D., president and CEO of Memorial Sloan Kettering Cancer Center, will deliver the next Flexner Discovery Lecture on May 5.
By Leigh MacMillan
April 21, 2016

Nobel laureate Betzig set for Discovery Lecture

Eric Betzig, Ph.D., who shared the 2014 Nobel Prize in Chemistry for the development of super-resolved fluorescence microscopy, will deliver the next Flexner Discovery Lecture on April 28.
By Leigh MacMillan
April 19, 2016

Myelin repair factors

Vanderbilt researchers show that two factors promote the repair of myelin, the nerve cell covering that deteriorates in diseases such as multiple sclerosis.
By Leigh MacMillan
April 5, 2016

Immune defenses in asthma

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.
By Leigh MacMillan
March 22, 2016

New treatment for Crohn’s disease

A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.
By Leigh MacMillan
March 8, 2016

Fat hormone’s role in zebrafish

The hormone leptin regulates glucose balance, but not fat stores, in zebrafish.
By Leigh MacMillan
1 … 49 50 51 52 53 … 80